Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 6, 2012

Sigma-Aldrich to Distribute AB Sciex Consumables

  • Sigma-Aldrich agreed to distribute worldwide AB Sciex’ portfolio of mass spectrometry-based tagging chemistries. The consumables, sold as SCIEX iChemistryTM Solutions, are intended for proteomics applications in basic research and applied markets.

    According to Sigma-Aldrich, the OEM agreement strengthens its mass spectrometry reagent business, reflects the company’s commitment to expanding its mass spec applications for the life sciences, and lays groundwork for a partnership with AB Sciex that will provide the basis for future joint development of mass spec consumables.

    The accord makes available all consumbles for quantitative proteomics and small molecule metabolite quantitation through Sigma-Aldrich. The company said the reagents complement its existing reagents portfolio for mass spectrometry.

    “Particularly in the Asia-Pacific region, this distribution agreement will provide the research community with easy and reliable access to AB Sciex’s unique reagents and consumables for mass spectrometry applications,” Josef Zihlmann, vp, marketing for Sigma-Aldrich, said in a statement.

    “In addition to establishing a complete toolset for mass spectrometry research with AB Sciex, we are continually adding to our collection of 60,000 antibodies that enable researchers to accurately discern dynamic states of proteins in key pathways throughout the proteome,” Zihlmann added.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »